Aprogen Biologics Inc.

KOSE:A003060 Stock Report

Market Cap: ₩151.7b

Aprogen Biologics Dividends and Buybacks

Dividend criteria checks 0/6

Aprogen Biologics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-76.3%

Buyback Yield

Total Shareholder Yield-76.3%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

Jun 20
Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

Apr 18
More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Jan 16
We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 20
Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Nov 24
Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A003060's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A003060's dividend payments have been increasing.


Dividend Yield vs Market

Aprogen Biologics Dividend Yield vs Market
How does A003060 dividend yield compare to the market?
SegmentDividend Yield
Company (A003060)n/a
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.9%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast (A003060) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A003060's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A003060's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A003060's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A003060 has not reported any payouts.


Discover strong dividend paying companies